News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
685,899 Results
Type
Article (39062)
Company Profile (279)
Press Release (646558)
Section
Business (203878)
Career Advice (1991)
Deals (35368)
Drug Delivery (85)
Drug Development (80806)
Employer Resources (168)
FDA (16089)
Job Trends (14805)
News (344570)
Policy (32438)
Tag
Academia (2531)
Alliances (49097)
Alzheimer's disease (1235)
Approvals (16024)
Artificial intelligence (133)
Bankruptcy (352)
Best Places to Work (11543)
Biotechnology (200)
Breast cancer (129)
Cancer (1117)
Cardiovascular disease (101)
Career advice (1660)
Cell therapy (238)
Clinical research (64291)
Collaboration (397)
Compensation (202)
COVID-19 (2532)
C-suite (96)
Data (1147)
Diabetes (153)
Diagnostics (6143)
Earnings (84834)
Employer resources (146)
Events (109587)
Executive appointments (316)
FDA (16640)
Funding (359)
Gene therapy (178)
GLP-1 (578)
Government (4326)
Healthcare (18691)
Infectious disease (2617)
Inflammatory bowel disease (106)
Interviews (308)
IPO (16305)
Job creations (3624)
Job search strategy (1417)
Layoffs (413)
Legal (7853)
Lung cancer (171)
Manufacturing (178)
Medical device (13180)
Medtech (13185)
Mergers & acquisitions (19151)
Metabolic disorders (405)
Neuroscience (1515)
NextGen Class of 2024 (6499)
Non-profit (4464)
Northern California (1497)
Obesity (234)
Opinion (179)
Patents (105)
People (56293)
Phase I (19966)
Phase II (28317)
Phase III (21116)
Pipeline (464)
Postmarket research (2554)
Preclinical (8500)
Radiopharmaceuticals (236)
Rare diseases (222)
Real estate (5890)
Regulatory (21533)
Research institute (2309)
Resumes & cover letters (349)
Southern California (1312)
Startups (3562)
United States (13671)
Vaccines (550)
Weight loss (168)
Date
Today (163)
Last 7 days (649)
Last 30 days (3653)
Last 365 days (35785)
2024 (32983)
2023 (40074)
2022 (51184)
2021 (55719)
2020 (54087)
2019 (46545)
2018 (35020)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (193)
Asia (37140)
Australia (6062)
California (3371)
Canada (1308)
China (255)
Colorado (149)
Connecticut (154)
Europe (79552)
Florida (469)
Georgia (121)
Illinois (347)
Indiana (197)
Kansas (96)
Maryland (581)
Massachusetts (2644)
Michigan (159)
Minnesota (275)
New Jersey (972)
New York (977)
North Carolina (708)
Northern California (1497)
Ohio (139)
Pennsylvania (853)
South America (1091)
Southern California (1312)
Texas (483)
Utah (91)
Washington State (365)
685,899 Results for "mentice inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mentice Receives Grant from Sweden’s Innovation Agency to Improve Synthetic Image Generation
Mentice has received a 3 million SEK grant from the Swedish government agency for innovation, Vinnova, to improve realism in Mentice virtual reality software environment with a focus on synthetic image generation.
November 9, 2022
·
1 min read
Business
Mentice and Acandis GmbH announce a 3-year agreement for Mentice Ankyras clinical support software solutions at a value of 8.9mSEK
Mentice AB (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that Acandis, Pforzheim, a leading innovator of minimal invasive devices for the treatment of neurovascular diseases, has signed a 3-year collaboration agreement to further develop the Acandis clinical support platform and supply their customers with Mentice Ankyras clinical support software solutions.
October 25, 2022
·
3 min read
Deals
Mentice AB (STO: MNTC) completes the acquisition of ANKYRAS
Mentice AB (STO: MNTC) (“Mentice”) Mentice today confirms the acquisition of the Ankyras business from Galgo Medical SL, as previously communicated via the press release on 9th June 2022, now has been completed.
June 30, 2022
·
1 min read
Mentice AB (publ) receives an order of USD 540,000 for simulation solutions from Corewell Health, Grand Rapids, Michigan, USA
Mentice AB, Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced that Corewell Health, Grand Rapids, Michigan USA, has signed an agreement to acquire Mentice VIST® simulation solutions for an order of USD 540,000.
December 30, 2022
·
1 min read
Mentice AB (publ) receives an order of USD 620,000 for simulation solutions and development services
Mentice AB, Gothenburg announced that a leading global healthcare technology company, has signed an agreement to acquire Mentice VIST® simulation solutions and development services, for an order of USD 620,000.
September 23, 2022
·
2 min read
Business
Mentice publishes the company’s interim report for the period April - June 2022
During the second quarter Mentice acquired the assets of Ankyras from Galgo Medical. Ankyras develops applications for precision medicine and will take Mentice into the operating room with a regulatory approved solutions assisting physicians in their aim to improve the outcome for patients.
July 21, 2022
·
3 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Deals
Mentice AB (publ) receives an order of 1,1 million USD for simulation solutions from Beijing Huanya Zhitong on behalf of the Chinese Medical Education Association.
Mentice AB (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that Beijing Huanya Zhitong, Beijing, China, has signed an agreement to acquire Mentice VIST® simulation solutions for an order of 1,1 million USD.
December 19, 2022
·
1 min read
Press Releases
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
November 26, 2024
·
9 min read
Mentice receives an initial order of USD 1.93million for simulation solutions and development services from Medtronic
Mentice, Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced that Medtronic, Dublin, a global healthcare technology leader, has signed an agreement to acquire Mentice VIST® simulation solutions and development services, in an initial order of USD 1.93 million.
June 29, 2022
·
1 min read
1 of 68,590
Next